While an inverse association of the HIF-1α Pro582Ser polymorphism with diabetic nephropathy risk has been identified in genetic studies of patients and mouse models, its translation into clinical and therapeutic research is not yet available (224). This evidence concerns the gene HIF1A and diabetic kidney disease.